| Full text | |
| Author(s): |
Luciana Scarlazzari Costa
[1]
;
Maria do Rosário Dias de Oliveira Latorre
[2]
;
Mariliza Henrique da Silva
;
Daniela Vinhas Bertolini
;
Daisy Maria Machado
;
Sidnei Rana Pimentel
;
Heloísa Helena de Sousa Marques
Total Authors: 7
|
| Affiliation: | [1] Universidade de São Paulo (USP). Faculdade de Saúde Pública. - Brasil
[2] USP. Faculdade de Saúde Pública. Departamento de Epidemiologia
Total Affiliations: 7
|
| Document type: | Journal article |
| Source: | Jornal de Pediatria; v. 84, n. 1, p. 41-46, 2008-02-00. |
| Field of knowledge: | Health Sciences - Collective Health |
| Abstract | |
OBJECTIVE: To validate and evaluate the reproducibility of a self-efficacy (SE) scale for adherence to antiretroviral therapy in children and adolescents with HIV/AIDS, taking into account the perspective of parents/guardians. METHODS: The study was carried out at the Hospital-Dia, Centro de Referência e Treinamento em DST/AIDS (CRT/SP), in São Paulo, Brazil. The parents/guardians of 54 children and adolescents aged 6 months to 20 years were interviewed during routine consultations at our service. Data on SE were collected using the Self-Efficacy for Following Anti-Retroviral Prescription Scale, and SE scores were calculated in two different ways: factor analysis and a predefined formula. The scale's internal consistency was verified using Cronbach's acoefficient. Validity was tested by comparing the mean scores of a group of patients who did adhere to antiretroviral treatment with those of a group that did not (Mann-Whitney test) and by calculating the Spearman correlation coefficient for agreement between scores and clinical parameters. Reproducibility was verified using the Wilcoxon test, intraclass correlation coefficients (r icc) and Bland-Altman plots. RESULTS: The SE scale demonstrated good internal consistency (a= 0.87) and good reproducibility (r icc = 0.69 and r icc = 0.75). In terms of validity, the SE scale was capable of differentiating adherent patients from those who did not adhere to their antiretroviral treatment (p = 0.002) and exhibited a significant correlation with CD4 counts (r = 0.28; p = 0.04). CONCLUSIONS: The SE scale can be used to assess adherence to antiretroviral therapy in children and adolescents with HIV/AIDS, taking into account the perspective of parents/carers. (AU) | |